Artivil 60mg Injection

Artivil 60mg Injection

Artesunate IP Sterile 60mg
  • Each Vial contains:
  • Artesunate IP Sterile 60mg
  • The pack contains :
  • 1ml ampoule of Sodium Bicarbonate Injection IP
  • 5ml ampoule of Sodium Chloride Injection IP

Artivil Injections contain Artesunate 60mg

Parenteral artesunate is the treatment of choice for all severe malaria. Furthermore, artesunate is simpler and safer to use. It can quickly and reliably control the acute attack and cerebral type of malaria. It is effective against plasmodium falciparum and plasmodium vivax, especially against malaria parasites resistant to chloroquine. Artesunate has been reported to clear fever in patients with severe falciparum malaria 16-25 hours after parenteral administration.

  • Dosage
  • Indications
  • Contraindication
  • Side-effects
  • Precautions
  • Storage

As Recommended by WHO.

  • Dosage: Adult: 2.4 mg/kg/ Body weight at 0, 12, 24 hrs (Day 1) Then 2.4 mg/kg/ day till the patient can swallow the tablets.
  • Children: 1.2mg/kg/ day for 5 days (Maximum dose given up to 60mg)
Artivil Injection is used in the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms:
  • Chloroquine resistant malaria
  • Cerebral malaria
It may not be recommended to consume Artivil Injection if you have the following diseases, medical or physical conditions:
  • Breastfeeding
  • First 3 months of pregnancy
  • Hypersensitive

Drug-induced fever can occur. Neurotoxicity has been observed in animal studies but not in humans. In view of the uncertainty about toxic effects, caution should be exercised when more than one 3-day treatment is given. Cardio toxicity has been observed following administration of high doses.

Parenteral artesunate should be used for the treatment of severe falciparum malaria only where there is evidence that the antimalarial efficacy of quinine is declining.

The powder for injection is difficult to dissolve and care should be taken to ensure that it is completely dissolved before parenteral administration. It should always be used immediately following reconstitution. If the solution is cloudy or a precipitate is present, the parenteral preparation should be discarded.

Use in pregnancy:
Little experience has been gained with the use of this drug in pregnancy but the parenteral preparation should not be withheld if it is considered life-saving to the mother.

Store in cool place. Protect from light. Keep out of reach of children.

Get In Touch

Head Office

Viilbery Healthcare Pvt. Ltd. Plot No. P- 64, Milap Nagar,
M. I. D. C Residential Zone Near AIMS Hospital, Dombivili
East, Thane - 421 203, Maharashtra, India.

Phone No

+91-251-2424221 / 2446311 / 2434221